Period Ending | Jan 30, 2012 | Oct 30, 2011 | Jul 30, 2011 | Apr 29, 2011 |
---|
Total Revenue
|
30,036,000
|
32,122,000
|
31,189,000
|
31,632,000
| Cost of Revenue | 23,313,000 | 25,561,000 | 23,700,000 | 23,887,000 | |
Gross Profit
|
6,723,000
|
6,561,000
|
7,489,000
|
7,745,000
| |
|
Operating Expenses |
|
Research Development | 786,000 | 829,000 | 812,000 | 815,000 |
|
Selling General and Administrative | 3,367,000 | 3,577,000 | 3,402,000 | 3,370,000 |
|
Non Recurring | 62,000 | 1,178,000 | 168,000 | 179,000 |
|
Others | 466,000 | 411,000 | 358,000 | 413,000 |
|
|
|
Total Operating Expenses | 4,681,000 | 5,995,000 | 4,740,000 | 4,777,000 | | |
Operating Income or Loss
|
2,042,000
|
795,000
|
2,520,000
|
2,968,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,821,000 | 165,000 | 2,628,000 | 2,892,000 |
|
Interest Expense |
-
| (229,000) | 229,000 |
-
|
|
Income Before Tax | 1,821,000 | 394,000 | 2,399,000 | 2,892,000 |
|
Income Tax Expense | 353,000 | 155,000 | 473,000 | 588,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,468,000 | 239,000 | 1,926,000 | 2,304,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,468,000
|
239,000
|
1,926,000
|
2,304,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,468,000
|
239,000
|
1,926,000
|
2,304,000
|
|